Dottikon ES Holding AG (DESN.SW) stock: key figures, P/E, revenue and dividend

Materials · Switzerland · ISIN CH0582581713

Price
275.50 CHF
Market cap
3.81 bn CHF
P/E (2026)
36.76
P/S (2026)
8.90
Dividend yield
0.00 %
Net margin
24.07 %
Return on equity (ROE)
9.39 %
Return on assets (ROA)
7.31 %

Dottikon ES Holding AG financials

Fiscal year20252026
Revenue385.00 m CHF428.00 m CHF
Gross profit259.00 m CHF272.00 m CHF
Operating income122.42 m CHF116.76 m CHF
EBIT118.00 m CHF117.00 m CHF
Net income105.00 m CHF103.00 m CHF
Diluted EPS – continuing operations7.64 CHF7.49 CHF

Full history since 2002, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Dottikon ES Holding AG

Dottikon ES Holding AG manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical industries. The company's chemicals and intermediates include amines, anilines, azaindoles, benzimidazoles, benzoic acid derivatives, benzyl compounds, boron building blocks, chiral compounds, cyclohexane derivatives, cyclopropyl building blocks, indazoles, indoles, N-heterocycles, nitrate esters, nitroaromatic compounds, O-heterocycles, phenols and anisoles, and pyridine building blocks. It also offers Dottisol, a non-GMO isosorbide dimethyl ether for application as a solubility enhancer in cosmetic, pharma, and agro products, as well as a performance additive in various industries. In addition, the company is involved in recycling and waste treatment which includes the recycling, thermal recovery, and high-temperature incineration of waste streams, as well as wastewater treatment and purification activities. Further, it offers chemical custom manufacturing, nitrosamine risk assessment, and containment services; and performance chemicals, including aromatic and alicyclic diamines, bio-based organ silanes, and phlegmatized azides. The company was founded in 1913 and is headquartered in Dottikon, Switzerland. Dottikon ES Holding AG operates as a subsidiary of EVOLMA Holding AG.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 21.10.2026. Details in the risk notice.

Dottikon ES Holding AG stock (DESN.SW): P/E, revenue, dividend | finmetric